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Abstract
Background: The number of hip, knee and shoulder arthroplasties continues to rise worldwide. The Organization
for Economic Cooperation and Development has launched an initiative (called PaRIS Initiative) for the systematic
collection of Patient Reported Outcome Measures (PROMs) in patients undergoing elective hip and knee
arthroplasty. The Rizzoli Orthopedic Institute (IOR) was selected as a pilot center for the launch of the Initiative in
Italy given that IOR hosts the Registry of Orthopedic Prosthetic Implants (RIPO), a region-wide registry which
collects joint implant data from all the hospitals in the Emilia-Romagna Region. In this specific geographic area
information related to PROMs after joint replacement is unknown. This paper describes the protocol of a study
(PaRIS-IOR) that aims to implement the collection of a set of PROMs within an existing implant registry in Italy. The
study will also investigate the temporal trend of PROMs in relation to the type of prosthesis and the type of
surgical intervention.
Methods: The PaRIS-IOR study is a prospective, single site, cohort study that consists of the administration of
PROMs questionnaires to patients on the list for elective arthroplasty. The questionnaires will be administered to
the study population within 30 days before surgery, and then at 6 and 12 months following surgery. The study
population will consist of consecutive adult patients undergoing either hip, knee or shoulder arthroplasty. The
collected data will be linked with those routinely collected by the RIPO in order to assess the temporal trend of
PROMs in relation to the type of prosthesis and the type of surgical intervention.
Discussion: The PaRIS-IOR study could have important implications in targeting the factors influencing functional
outcomes and quality of life reported by patients after hip, knee and shoulder arthroplasty, and will also represent
the first systematic collection of PROMs related to arthroplasty in Italy.
Trial registration: Protocol version (1.0) and trial registration data are available on the platform
www.clinicaltrial.gov with the identifier NCT03790267, first posted on December 31, 2018.
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Background
The number of hip, knee and shoulder arthroplasties
continues to rise worldwide [1]. Arthroplasties are
increasing due to several factors, such as the higher lon-
gevity and higher osteoarthritis incidence [2–4]. This
represents a challenge for healthcare providers, given its
consequences on patients’ functional outcomes and
quality of life, and related costs.
The World Health Organization (WHO) has defined
patient centeredness as a fundamental characteristic for
the quality of healthcare [5]. Patient centeredness can be
improved through the collection and analysis of func-
tional outcomes and quality of life reported by patients,
the so-called Patient-Reported Outcome Measures
(PROMs). PROMs take the perspective of the patient,
and typically represent outcomes that matter more to
patients, such as impact on usual activities and self-care,
and are described in a language that is easier to under-
stand than clinical measures [1]. Measuring PROMs in
patients who have undergone arthroplasty surgery can
be a key tool to improve healthcare quality. PROMs are
routinely collected in the implant registries of several
OECD countries [6, 7]. For example, the National Joint
Registry (NJR) in the United Kingdom has one of the
largest PROMs collections of patients undergoing hip,
knee or shoulder arthroplasty [8]. Studies from Sweden,
Norway, and the Netherlands showed that adding the
patient perspective by integrating data on functional out-
comes and quality of life to selected health information
systems, such as registries, gives relevant benefits in
terms of quality improvement [9–11]. However, there
are differences in the quality of life in such different
countries. One important consideration when using such
measures in multi-country studies is that many geo-
graphical factors (ethnicity, culture, etc.) may potentially
affect responses in patient reported outcomes. This can
make the evidence originated from a country registry (or
a PROMs collection) non-generalizable. In fact, multiple
studies comparing various national arthroplasty regis-
tries highlighted difference in pre-operative patients’
characteristics and PROMs [12–16], thus cautioning
from within-countries comparison and suggesting risk-
adjustment prior to making conclusions about apparent
differences in outcome.
Moreover, PROMs assessment is not extensively
adopted in many contexts due to the difficulty in sys-
tematically recording information reported by patients
before and after the surgical procedure. A standard of
PROMs collection is therefore necessary in as many
countries as possible. Accordingly, the Organization for
Economic Cooperation and Development (OECD) has
launched an initiative (Patient-Reported Indicator Sur-
vey, PaRIS) for the systematic collection of PROMs in
patients undergoing elective hip and knee prosthetic
arthroplasty at 6 and 12months post-operatively [17].
Creating a network of standardized collections of
PROMs in all OECD countries will help investigate the
determinants of quality in healthcare and to carry out
national and international comparisons.
The IRCCS Rizzoli Orthopedic Institute (IOR) in Bol-
ogna, Italy, was selected as one of the pilot centers to
launch the PaRIS initiative in Italy, with the aim to
accelerate the adoption and reporting of validated, stan-
dardized, internationally comparable patient-reported
indicators. Since 2000, local health authorities appointed
IOR to implement and manage the Registry of Orthopedic
Prosthetic Implants (RIPO), a region-wide registry which
collects joint implant data from all public and private hos-
pitals in the Emilia-Romagna Region in Italy, an area of
4.5 million inhabitants [18, 19]. In this specific geographic
region the information related to patient reported func-
tional outcomes after joint replacement have never been
collected. Therefore, information on health-related quality
of life in this specific population is not available.
This paper describes the protocol of a study (PaRIS-
IOR) that aims to implement the collection of a set of
PROMs within an existing implant registry in Italy. The
study will also investigate the temporal trend of PROMs
in relation to the type of prosthesis and the type of
surgical intervention. This can be useful for clinicians,
surgeons and policy-makers in order to improve health-
care quality in a specific geographic region.
Methods
Design and setting of the study
The PaRIS-IOR study is a prospective, single site, cohort
study that will be conducted at the IOR, a third-level
mono-specialty hospital in Bologna, Italy. About 60% pa-
tients admitted to IOR for joint replacement surgeries
come from other regions or countries, therefore IOR
population can be considered nationally representative.
PROMs data will be linked to the Registry of Orthopedic
Prosthetic Implants (RIPO). This registry collects on a
regular basis data of patients undergoing hip, knee and
shoulder replacement. Collected data include patients’
demographics, pathology leading to joint replacement,
type of surgical procedures, and the characteristics of
the implant.
PROMs questionnaires will be given to patients await-
ing surgery by specifically trained researchers within 30
days before surgery for hip, knee or shoulder arthro-
plasty, and then at 6 and 12 months following surgery.
PROMs data will be merged with those routinely
recorded in the RIPO registry database [20] and with
hospital discharge records to determine the frequency of
adverse events, implant failures and hospital re-
admissions.
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Study population and recruitment procedures
The study population will include consecutive adult pa-
tients undergoing elective hip, knee or shoulder arthro-
plasty admitted at the 6 operative units that perform hip,
knee and shoulder arthroplasty (Orthopedic and Trauma-
tological Clinic 1, Orthopedic and Traumatological Clinic
2, Orthopedic and Traumatologic Clinic 3, Reconstructive
Orthopedic Surgery - Innovative Techniques, Shoulder
and Elbow Surgery, Prosthetic Surgery and revisions of
hip and knee implants).
For elective hip, knee and shoulder surgery per-
formed at the 6 operative units, the IOR has activated
a Pre-Admission Plan (PAP). About 90% of patients
who undergo elective surgery are included in the
PAP, visited in a dedicated clinic within the hospital,
where an orthopedic surgeon confirms the indication
for joint replacement and an anesthesiologist assesses
the patient’s eligibility to undergo surgery. From 15
to 30 days before the admission, patients are con-
tacted by phone and notified about the admission
date and the admission procedures. For these patients
the recruitment will be carried out in a specific area
during the pre-admission visit. Patients not included
in the PAP (about 10%) will be enrolled directly at
the operative units before the surgery.
Inclusion criteria are:
1. Males and females
2. Age 18–95 years
3. Elective primary hip, knee or shoulder arthroplasty
4. Willingness to be enrolled in the study, by signing
the informed consents
Exclusion criteria are:
1. Severe cognitive impairment
2. Arthroplasty for musculoskeletal cancer
3. Patient not eligible for surgical procedures
Study phases and intervention
The study consists of 3 phases (Fig. 1). At baseline, eli-
gible patients that meet the inclusion criteria will be
identified. The evaluation will be performed in the PAP
clinic in the 15–30 days preceding the intervention or in
the ward of the operative unit just before surgery; in this
phase, patients who agree to participate to the study will
be administered two self-report questionnaires (EQ-5D-
3 L for all patients and the joint-specific questionnaire).
The staff in charge of the distribution and collection of
the questionnaires will follow a progressive number that
will be the same used to input the data in the CRF and
to match the patient record with the RIPO’s unique
anonymized identification code.
Fig. 1 PaRIS-IOR flowchart including the pre-study routine practice for data collection in RIPO registry and the study phases (baseline, follow-up
and data analysis)
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The follow-up phase will be carried out at 6 and 12
months by mailing the same 2 questionnaires; partici-
pants will be asked to return the filled questionnaires. In
case the questionnaires are not mailed back within 1
month, the participants will receive a reminder phone
call.
Data analysis will be performed by the RIPO staff with
the methodological support of the Biomedical and
Health Services Research Unit of the University of
Bologna.
Instruments
Four validated questionnaires will be used in the study.
One questionnaire (Euro Quality 5 Dimensions, EQ-5D-3
L) for the general assessment of the patient health status
will be administered to all patients enrolled in the study
[21]. According to the surgical procedure, patients will be
administered with a joint-specific questionnaire: the Hip
disability and Osteoarthritis Outcome Score – Physical
function Short-form (HOOS-PS) for patients undergoing
hip replacement [22]; the Knee injury and Osteoarthritis
Outcome Score – Physical function Short-form (KOOS-
PS) for patients undergoing knee replacement [23]; the
American Shoulder and Elbow Surgeons Standardized
Shoulder Assessment Form (ASES), for patients undergoing
shoulder implants. This last questionnaire will be
administered in a modified version that does not include
the assessments performed by the orthopedic surgeon [24].
Euro quality 5 dimensions questionnaire (EQ-5D-3 L)
The Euro Quality 5 Dimensions EQ-5D is a standardized
measure of health related quality of life used worldwide
[25, 26]. It is a self-report instrument consisting of a de-
scriptive system with five dimensions (mobility, self-care,
usual activities, pain/discomfort, and anxiety/depression)
and a visual analog scale (EQ-VAS) to measure overall
health.
There are two versions of the instrument for use in
the adult population, EQ-5D-3 L and EQ-5D-5 L. The
version of EQ-5D used in this study (EQ-5D-3 L) uses
three levels of severity (1 = no, 2 = some, 3 = extreme
problems or unable to) in each dimension. We have de-
cided to use the version with three response options
(EQ-5D-3 L) rather than the version with five response
options EQ-5D-5 L because it is shorter, faster and easier
to administer in clinical settings where elderly people
are treated. The EQ-5D health states, defined by the EQ-
5D descriptive system, may be converted into a single
summary score by applying weights to each of the levels
in each dimension, as is typically done in cost utility
analysis.
The visual analogue scale (EQ-VAS) will be used by
participants to rate their health status between the worst
conceivable health state (score = 0) to the best conceiv-
able health state (score = 100).
The Italian version of EQ-5D has been validated by Sa-
voia et al. [21].
Hip disability and osteoarthritis outcome score – physical
function short-form (HOOS-PS)
The HOOS-PS is the 5-item the short-form version of
the Hip disability and Osteoarthritis Outcome Score
(HOOS), developed in English in 2003 [27, 28] to meas-
ure pain, symptoms, activity of daily living, sport and re-
creation function and hip-related quality of life from the
patients’ perspective. The 5 items included in the short
form measure physical function and are rated on five-
point Likert scale (none, mild, moderate, severe, ex-
treme), where 0 indicates no problems and 4 extreme
problems. Item score can be transformed to a 0–100
scale with 0 indicating the worst problems and 100 indi-
cating no problems The HOOS was translated and
adapted to Italian, according to the international guide-
lines provided by Torre et al. [22].
Knee injury and osteoarthritis outcome score – physical
function short-form (KOOS-PS)
The KOOS-PS is the 7-item short-form of Knee injury
and Osteoarthritis Outcome Score developed in English
by Roos et al. [29] to measure pain, symptoms, activity
of daily living, sport and recreation function and knee-
related quality of life from the patients’ perspective.
Items are rated on a five-point Likert scale, where 0 indi-
cates no problems and 4 extreme problems and normal-
ized to a 0–100 scale, where 0 indicates extreme
problems and 100 no problem. The Italian version of
KOOS has been validated by Monticone et al. [23].
American shoulder and elbow surgeons standardized
shoulder assessment form (ASES)
The American Shoulder and Elbow Surgeon Standard-
ized Shoulder Assessment Form (ASES) was developed
in 1994 for the assessment of patients with shoulder
problems. It consists of a self-report section and a sec-
tion including the results of physical examination filled
out by the medical staff. The questionnaire used in the
present study will be administered in a modified version
that does not include the assessments performed by the
orthopedic surgeon.
The ASES Subjective Form includes 11 items that
measure pain (1 item) and function (10 items). The re-
sponse to the pain question is rated on a 10-cm visual
analog scale (VAS). The 10 items in the function area
measure daily living activities.
The ASES also includes two general items: doing usual
work and doing usual sport. These items are rated from
0 (unable to do) to 3 (not difficult). The final score is
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obtained by multiplying the pain score by 5 and the cu-
mulative activity score by 5/3 and then adding the two
scores. The total score of the questionnaire ranges from
0 (=worst outcome) to 100 (=best outcome). The ASES
has been validated in Italian by Padua et al. [24].
Endpoints
The outcomes of interest are functional and quality
of life outcomes, measured through the total scores
and the subscales of the administered questionnaires.
For the joint-specific functional scales, we will use the
total score; for the EQ-5D we will use the scores of
the single dimensions, along with a VAS total score
on a 0–100 scale to measure the overall health status.
Other outcomes include adverse events, implant fail-
ures and hospital re-admissions at 30 and 90 days
after discharge.
Sample size
The study will include all patients undergoing elective
hip, knee and shoulder arthroplasty in the 6 Operative
Units, who will meet the inclusion criteria. We plan to
enroll 1700 patients, of which 1100 with hip replace-
ment, 500 with knee replacement and 100 with shoulder
replacement in 2019, according to the number of arthro-
plasties performed at the IOR in 2016. We expect a 10%
rejection rate and a 40% follow-up drop-out rate.
Statistical analyses
Patients’ demographic and clinical variables (gender,
age, body-mass index, comorbidity, clinical history,
diagnosis) and surgical details (type of surgical pro-
cedure, surgical technique, antimicrobial prophylaxis,
type of implant, acute and post-acute complications,
and implant failures) will be extracted from RIPO.
Adverse events and 30 and 90 days hospital readmis-
sions will be extracted from the hospital discharge
record database. For statistical analyses patients will
be stratified according to the anatomic site of the sur-
gical procedure (hip, knee and shoulder arthroplasty).
Patients with a bilateral implant will be included in
the analyses just once.
To analyze the temporal trend of functional and quality
of life outcomes and to identify the factors influencing
their trend, generalized estimation equations (GEE) and
structural equation models (SEM) will be used. These
techniques allow to obtain robust estimates even in pres-
ence of missing data. We estimated a 40% attrition rate
and expected that non-compliance in returning the
questionnaires is not linked to a systematic reason (for ex-
ample, baseline level of joint impairment). However, it is
possible that patients with specific characteristics (for in-
stance very old patients or patients with less severe
conditions) do not return the follow-up questionnaire
because they are unable or not interested in providing in-
formation on their functional status. If there is a differen-
tial response to follow-up related to patients’ conditions,
follow-up data may be biased. To determine the possible
presence of this bias, sensitivity analyses will be
conducted.
Study duration and timeline
The study will have an overall duration of 30 months
and will be considered in any case completed 6 months
after the recruitment target is achieved.
The study timeline is the following:
 Months 1–12: Selection and enrollment of the
patients and database implementation.
 Months 6–24: Follow up (6 and 12 months) and
database implementation.
 Months 24–30: Analysis of data and final
dissemination of results.
Due to the easy design and the low clinical and
organizational impact of the study, the collection and
analysis of PROMs are expected to continue and become
structural in the RIPO registry beyond the end of the
study. Within the OECD’s PaRIS Initiative it is planned
to generate a considerable amount of internationally
comparable PROMs data.
Ethics and dissemination
This study has been approved by the AVEC research eth-
ics committee board [30], ID PG0013646 on 11-29-2018.
All patients will sign two written informed consents, one
for privacy and one for participation. The protocol of the
study is also available on the clinicaltrials.gov platform (ID
NCT03790267). The study findings will be reported for
publication in peer-reviewed journals.
Financial burden
Considering the characteristics of the study, the costs
are related to personnel (2 RIPO units for a total of 32,
500 € for the study duration) and postal expenses (fore-
seen in 8000 € considering the number of patients to be
enrolled in the study). These costs will be incurred
within the RIPO and IOR funds, respectively.
Discussion
This paper described the protocol of the PaRIS-IOR
study. The study will integrate and combine PROMs
related to patients undergone joint surgery with implant
registry data and will contribute to investigate the
temporal trend of PROMs in relation to the type of
prosthesis and the type of surgical intervention. This will
be useful for clinicians, surgeons and policy-makers to
improve healthcare quality and the management of
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patients undergoing hip, knee and shoulder arthroplasty
in a specific geographic region where information on
health-related quality of life after elective joint replace-
ment is unknown. The outcomes of highly common pro-
cedures such as joint replacement should be ideally
collected within a specific country or a geographical re-
gion. In fact, differences in both pre-operative status and
outcomes across international patient groups have been
highlighted in previous studies. In a study of 12 Euro-
pean countries evaluating patients with advanced hip
osteoarthritis, the level of pre-operative pain and disabil-
ity have been reported to vary across countries [16] .
Similarly, Lingard et al. [31] reported that patient from
United Kingdom had significantly worse clinical out-
comes one and 2 years after total knee arthroplasty re-
spect to those from USA and Canada, after adjusting for
confounding factors. Moreover, Gromov et al. [15] re-
ported greater pain and poorer function in US than in
the European patients. Thus, the creation of this natio-
nal\regional registry-based PROMS collection would
help to further clarify this controversy.
Moreover, the present study consists in measuring
the functional and quality of life outcomes of the par-
ticipants and combining them with the clinical, surgi-
cal and organizational data routinely recorded into
the RIPO registry. There are conflicting results in the
literature on which surgical and organizational factors
are associated with an improvement in PROMs after
joint surgery [11, 27, 28]. Prodinger and Taylor
highlighted [9] the role of PROMs in realizing a bio-
psycho-social perspective on health. On the other
hand, the same authors reported that one of the main
concerns for using PROMs in monitoring quality of
healthcare is the lack of standards on what change in
PROMs scores should be achieved when conducting a
surgery for arthroplasty. Amlie et al. [11] found worse
outcomes 1–3 years after primary total hip arthro-
plasty performed with the direct lateral approach ra-
ther than the anterior and posterolateral approaches,
using PROMs data from 1476 patients. Conversely,
Peters et al. found no relevant differences in PROMs
improvements between the anterior and posterolateral
approaches [10]. The PaRIS-IOR study will contribute
to increase the consistency of scientific evidence in
this area.
The PaRIS-IOR study, beyond providing specific in-
formation on interventions and outcomes, can help in
building data collection standards potentially useful in
comparison analyses. As proposed by OECD, it is im-
portant to have shared and standardized measures to
make comparisons at the international level, but also
to provide insights for clinical audit activities at a na-
tional, regional and single organization level. Health-
care professionals can improve patient selection and
profiling for the most suitable surgical technique or
type of prosthesis. This should be done in order to
increase appropriateness, effectiveness, safety, and
therefore quality.
The study has several strengths. First, the collection
of PROMs within the longest running implant registry
in Italy may provide important insights from a geo-
graphical region where systematic collections of
PROMs do not exist yet. A second strength is the
collection of data and PROMs related to shoulder
arthroplasty. The high number of shoulder arthroplas-
ties performed at the IOR (> 100 per year) allows ex-
tending the collection of functional and quality of life
outcomes to this cohort of patients. Moreover, the
design of the PaRIS-IOR study includes the collection
of PROMs at 3 different time points: before surgery,
at 6 and 12 months. This will increase the informa-
tion related to patients’ reported outcomes, following
them over a long period of time.
This study has two important limitations. First, the
study will be conducted in one center, a third-level
mono-specialty hospital. This implies the risk of
selecting patients with a more severe case-mix. In the
future, it is desirable for the study to be extended
also to the first and second level centers where the
remaining joint surgery interventions are carried out
in the Emilia-Romagna region. Secondly, the collec-
tion of data will take place using paper forms for the
collection of functional and the quality of life out-
comes of the study participants. This is mainly due to
the low compliance to the use of new technologies by
the elderly patients who will be enrolled in the study.
Instead, this should take place relying on the increas-
ing use of digital application for the remote record of
clinical and functional outcomes, including PROMs.
We are evaluating options to digitally record PROMs
data and integrate them automatically into each pa-
tient’s electronic medical record and then in the
registry, overcoming the need for paper forms. From
this point of view, however, the main problems relate
to security, privacy and interoperability of the
systems.
In summary, we believe this study could have im-
portant implications in targeting the factors influen-
cing the evolution of functional and quality of life
outcomes reported by patients after hip, knee and
shoulder arthroplasty. Widening the view, the study
will also represent the first systematic collection of
PROMs related to arthroplasty in Italy and will con-
tribute to increase the adoption of such important
outcome measures to improve healthcare quality.
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